Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2013-03-15

Clinical Trial Update: A Phase I Clinical Trial With Whole Virus Inactivated Influenza H5N1 Vaccine in Healthy Adolescents and Adults [Phase 1]

View source ↗

Summary

A Phase I trial evaluating a whole-virus inactivated influenza H5N1 vaccine in healthy adolescents and adults has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Whole virus inactivated influenza H5N1 vaccine (inactivated influenza A/H5N1 vaccine)

Snippet

Sponsor: Jiangsu Province Centers for Disease Control and Prevention | Conditions: Healthy | Phase 1 | Status: WITHDRAWN